Ovarian Cancer Recurrent Clinical Trials in Shanghai, Shanghai Municipality
2 recruitingShanghai, Shanghai Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer
Ovarian Cancer Recurrent
Obstetrics & Gynecology Hospital of Fudan University296 enrolled1 locationNCT06791460
Recruiting
Phase 2
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
Primary Peritoneal CarcinomaFallopian Tube CancerOvarian Cancer Recurrent
Shanghai Gynecologic Oncology Group167 enrolled5 locationsNCT03983226